These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25488378)

  • 1. The role of the follicular isthmus in the evolution of keratoacanthoma.
    Kossard S
    J Cutan Pathol; 2015 Apr; 42(4):299-300. PubMed ID: 25488378
    [No Abstract]   [Full Text] [Related]  

  • 2. The changes in the expression levels of follicular markers in keratoacanthoma depend on the stage: keratoacanthoma is a follicular neoplasm exhibiting infundibular/isthmic differentiation without expression of CK15.
    Misago N; Takai T; Toda S; Narisawa Y
    J Cutan Pathol; 2014 May; 41(5):437-46. PubMed ID: 24666173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudoepitheliomatous hyperplasia of follicular origin and malignant melanoma.
    Sánchez Yus E; Requena L
    J Cutan Pathol; 2001 Jul; 28(6):325-6. PubMed ID: 11401681
    [No Abstract]   [Full Text] [Related]  

  • 4. Keratoacanthoma and infundibulocystic squamous cell carcinoma.
    Kossard S; Tan KB; Choy C
    Am J Dermatopathol; 2008 Apr; 30(2):127-34. PubMed ID: 18360115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of class II beta-tubulin in non-melanoma cutaneous tumors.
    Roh JY; Kee SH; Choi JW; Lee JH; Lee JH; Lee ES; Kim YS
    J Cutan Pathol; 2007 Feb; 34(2):166-73. PubMed ID: 17244029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keratoacanthoma, committed stem cells and neoplastic aberrant infundibulogenesis integral to formulating a conceptual model for an infundibulocystic pathway to squamous cell carcinoma.
    Kossard S
    J Cutan Pathol; 2021 Jan; 48(1):184-191. PubMed ID: 32881028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corrigendum: Differential Immunoexpression of Inhibitory Immune Checkpoint Molecules and Clinicopathological Correlates in Keratoacanthoma, Primary Cutaneous Squamous Cell Carcinoma and Metastases.
    Lonsdorf AS
    Acta Derm Venereol; 2024 Sep; 104():. PubMed ID: 39233466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Cyclooxygenase-2 in Squamous Cell Carcinoma and Keratoacanthoma and its Clinical Significance.
    Hua HK; Jin C; Yang LJ; Tao SQ; Zhu XH
    Cell Biochem Biophys; 2015 Jun; 72(2):475-80. PubMed ID: 25575894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathologic assessment of depth of follicular invasion of squamous cell carcinoma (SCC) in situ (SCCis): Implications for treatment approach.
    Christensen SR; McNiff JM; Cool AJ; Aasi SZ; Hanlon AM; Leffell DJ
    J Am Acad Dermatol; 2016 Feb; 74(2):356-62. PubMed ID: 26670714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spindle Cell-Predominant Trichodiscoma With a Palisaded Arrangement of Stromal Cells.
    Ranson MA; Hamza S
    Am J Dermatopathol; 2019 Jul; 41(7):533-534. PubMed ID: 29621024
    [No Abstract]   [Full Text] [Related]  

  • 11. Crater/ulcerated form of infundibular squamous cell carcinoma: A possible distinct entity as a malignant (or high-grade) counterpart to keratoacanthoma.
    Misago N; Inoue T; Nagase K; Tsuruta N; Tara-Hashimoto A; Kimura H; Takahara K; Narita T; Narisawa Y
    J Dermatol; 2015 Jul; 42(7):667-73. PubMed ID: 25854192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tricholemmoma and clear cell squamous cell carcinoma (associated with Bowen's disease): immunohistochemical profile in comparison to normal hair follicles.
    Misago N; Toda S; Narisawa Y
    Am J Dermatopathol; 2012 Jun; 34(4):394-9. PubMed ID: 22452951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Considerations on the measurement of follicular squamous cell carcinoma.
    Fernandez-Flores A
    Am J Dermatopathol; 2013 Feb; 35(1):135-7. PubMed ID: 22067276
    [No Abstract]   [Full Text] [Related]  

  • 14. Malignant potential of keratoacanthoma.
    Butcher RB
    Laryngoscope; 1979 Jul; 89(7 Pt 1):1092-8. PubMed ID: 449552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trichoblastoma of the eyelid.
    Johnson TV; Wojno TH; Grossniklaus HE
    Ophthalmic Plast Reconstr Surg; 2011; 27(6):e148-9. PubMed ID: 21346671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ki-67 may be useful in differentiating between keratoacanthoma and cutaneous squamous cell carcinoma.
    Scola N; Segert HM; Stücker M; Altmeyer P; Gambichler T; Kreuter A
    Clin Exp Dermatol; 2014 Mar; 39(2):216-8. PubMed ID: 24524559
    [No Abstract]   [Full Text] [Related]  

  • 17. Keratoacanthoma: facts and controversies.
    Ko CJ
    Clin Dermatol; 2010; 28(3):254-61. PubMed ID: 20541676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Composite Fibrofolliculoma/Trichodiscoma With Vascular Mesenchymal Stromal Overgrowth.
    Tran TA; Carlson JA
    Am J Dermatopathol; 2016 Jul; 38(7):562-5. PubMed ID: 27322792
    [No Abstract]   [Full Text] [Related]  

  • 19. Proliferating cell nuclear antigen immunostaining in keratoacanthoma and squamous cell carcinoma of the skin.
    Royds JA; Stephenson TJ; Silcocks PB; Bleehen SS
    Pathologica; 1994 Dec; 86(6):612-6. PubMed ID: 7617390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two perplexing skin tumors: microcystic adnexal carcinoma and keratoacanthoma.
    Batsakis JG; el-Naggar AK; Weber RS
    Ann Otol Rhinol Laryngol; 1994 Oct; 103(10):829-32. PubMed ID: 7944178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.